Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1123-1129

  Griffiths, Richard J ^a   Smith, Mary Alice ^a   Roach, Marsha L ^a   Stock, Jeffrey L ^a   Stam, Ethan J ^a   Milici, A J ^a   Scampoli, Deborah N ^a   Eskra, James D ^a   Byrum, Robert S ^b   Koller, Beverly H ^b   McNeish, John D ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; LEUKOTRIENE; LIPOXYGENASE; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHEMOTAXIS; DISEASE ASSOCIATION; GENE TARGETING; HETEROZYGOTE; MOUSE; MULTIGENE FAMILY; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; BLOOD PROTEINS; CARRIER PROTEINS; COLLAGEN; FEMALE; HETEROZYGOTE; HUMANS; JOINTS; LEUKOTRIENES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; PERITONEAL CAVITY; STEM CELLS; ZYMOSAN;

EID: 17444440118     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1123     Document Type: Article

References (27)

1. Ford-Hutchinson, A.W. 1990. Leukotriene B4 in inflammation. Crit. Rev. Immunol. 10:1-14.
2. Samuelson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (Wash. DC). 220:568-575.
3. Ford-Hutchinson, A.W., M.A. Bray, M.V. Doig, M.E. Shipley, and M.J. Smith. 1980. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (Lond.). 286:264-265.
4. Dahlen, S.E., P. Hedqvist, S. Hammarstrom, and B. Samuelsson. 1980. Leukotrienes are potent constrictors of human bronchi. Nature (Lond.). 288:484-486.
5. Rouzer, C.A., T. Matsumoto, and B. Samuelsson. 1986. Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc. Natl. Acad. Sci. USA. 83:857-861.
6. Woods, R.J., J.F. Evans, D. Ethier, S. Scott, P.J. Vickers, L. Hearn, J.A. Heibein, S. Charleson, and I.I. Singer. 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
7. Woods, J.W., M.J. Coffey, T.G. Brock, I.I. Singer, and M. Peters-Golden. 1994. 5-lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035-2046.
8. Miller, D.K., J.W. Gillard, P.J. Vickers, S. Sadowski, C. Leveille, J.A. Mancini, P. Charleson, R.A.F. Dixon, A.W. Ford-Hutchinson, R. Fortin et al. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature (Lond.). 343:278-281.
9. Gillard, J., A.W. Ford-Hutchinson, C. Chan, S. Charleson, D. Denis, A. Foster, R. Fortin, S. Leger, C.S. McFarlane, H. Morton et al. 1989. L-663,536 (MK-886), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 67:456-464.
10. Dixon, R.A.F., R.E. Diehl, E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard, and D.K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature (Lond.). 343:282-284.
11. Hatzelmann, A., R. Fruchtmann, K.H. Mohrs, S. Raddatz, M. Matzke, U. Pleiss, J. Keldenich, and R. Muller-Peddinghaus. 1994. Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase. Agents Actions. 43:64-68.
12. Penrose, J.F., J. Spector, M. Baldasaro, K. Xu, J. Boyce, J.P. Arm, K.F. Austen, and B.K. Lam. 1996. Molecular cloning of the gene for human leukotriene C4 synthase. J. Biol. Chem. 271:11356-11361.
13. Goulet, J.L., J.N. Snouwaert, A.M. Latour, T.M. Coffman, and B.H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA. 91: 12852-12856.
14. Chen, X.-S., J.R. Sheller, E.N. Johnson, and C.D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature (Lond.). 372:179-182.
15. Wooley, P.H., H.S. Luthra, J.M. Stuart, and C.S. David. 1981. Type II collagen-induced arthritis. 1. MHC (I-region) linkage and antibody correlates. J. Exp. Med. 154:688-700.
16. Griffiths, R.J., E.R. Pettipher, K. Koch, C.A. Farrell, R. Breslow, M.J. Conklyn, M.A. Smith, B.C. Hackman, D.J. Wimberly, A.J. Milici et al. 1995. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 92:517-521.
17. Nickerson-Nutter, C.L., and E.D. Medvedeff. 1996. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation. Arthritis Rheum. 39:515-521.
18. Daumy, G.O., J.M. Merenda, A.S. McColl, G.C. Andrews, A.E. Franke, K.F. Geoghegan, and I.G. Otterness. 1986. Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli. Biochim. Biophys. Acta. 998:32-42.
19. Stewart, C.L. 1993. Production of chimeras between embryonic stem cells and embryos. Methods Enzymol. 225:823-855.
20. Roach, M.L., J.L. Stock, R. Byrum, B.H. Koller, and J.D. McNeish. 1995. A new embryonic stem cell line from DBA/ 1lacJ mice allows genetic modification in a murine model of human inflammation. Exp. Cell Res. 221:520-525.
21. Eskra, J.D., M.J. Pereira, and M.J. Ernest. 1986. Solid-phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products. Anal. Biochem. 154: 332-337.
22. Sweeney, F., J. Eskra, and T. Carty. 1987. Spectrophotometric monitoring of lipoxygenase and cyclooxygenase pathway activity using ionophore stimulated whole blood. Agents Actions. 21:393-396.
23. Wright, C., and J. Eskra. 1993. A universal automated method for solid-phase extraction, HPLC, and fractionation of biological fluids for drug level and eicosanoid quantitation by UV detection and enzyme immunoassay. Pharmaceutical Res. 10(Suppl.):S-57.
24. Hom, J.T., A.M. Bendele, and D.G. Carlson. 1988. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J. Immunol. 141:834-841.
25. Killar, L.M., and C.J. Dunn. 1989. Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin. Sci. 76:535-538.
26. Griffiths, R.J., S.W. Li, B.E. Wood, and A. Blackham. 1991. A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the knee joint and peritoneal cavity. Agents Actions. 32:312-320.
27. Evans, J.F., Y. Leblanc, B.J. Fitzsimmons, S. Charleson, D. Nathaniel, and C. Leveille. 1987. Activation of leukocyte movement and displacement of leukotriene B4 from leukocyte membrane preparations by (12R)-and (12S)-hydroxyeicosatetraenoic acid. Biochim. Biophys. Acta. 917:406-410.